QIAGEN has a truly global investor base comprised of more than 335 identified institutional investors distributed around the world, including more than a half in North America, about one-third in Europe and the remaining shares in the Asia-Pacific/Japan region. Members of the Managing Board and the supervisory Board in total held approximately 2.8 % of QIAGEN's outstanding common shares at the end of January 2019.
|BlackRock, Inc., United States||24,444||10.59|
|Sun Life Financial Inc., United States||13,508||5.85|
|PRIMECAP Management Company, United States||13,388||5.80|
|Wellington Management Company, United States||11,721||5.08|
|State Street Corp., United States||7,824||3.39|
|The Vanguard Group, Inc., United States||7,359||3.19|
Status: December 2019